Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system

被引:157
作者
Bymaster, FP [1 ]
McKinzie, DL
Felder, CC
Wess, J
机构
[1] Eli Lilly & Co, Lilly Res Lab, Lilly Corp Ctr, Neurosci Res Div, Indianapolis, IN 46285 USA
[2] NIDDKD, Bioorgan Chem Lab, Bethesda, MD 20892 USA
关键词
acetylcholine; gene targeting; knockout mice; muscarinic agonists; muscarinic receptors; xanomeline;
D O I
10.1023/A:1022844517200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this review we report recent findings on the physiological role of the five known muscarinic acetylcholine receptors (mAChRs) as shown by gene targeting technology. Using knockout mice for each mAChRs subtype, the role of mAChRs subtypes in a number of physiological functions was confirmed and new activities were discovered. The M, mAChRs modulate neurotransmitter signaling in cortex and hippocampus. The M-3 mAChRs are involved in exocrine gland secretion, smooth muscle contractility, pupil dilation, food intake, and weight gain. The role of the M-5 mAChRs involves modulation of central dopamine function and the tone of cerebral blood vessels. mAChRs of the M-2 subtype mediate muscarinic agonist-induced bradycardia, tremor, hypothermia, and autoinhibition of release in several brain regions. M-4 mAChRs modulate dopamine activity in motor tracts and act as inhibitory autoreceptors in striatum. Thus, as elucidated by gene targeting technology, mAChRs have widespread and manifold functions in the periphery and brain.
引用
收藏
页码:437 / 442
页数:6
相关论文
共 42 条
[1]  
Anagnostaras S.G, 2000, SOC NEUR ABSTR, V26, P1509
[2]   M1 muscarinic acetylcholine receptors activate extracellular signal-regulated kinase in CA1 pyramidal neurons in mouse hippocampal slices [J].
Berkeley, JL ;
Gomeza, J ;
Wess, J ;
Hamilton, SE ;
Nathanson, NM ;
Levey, AI .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2001, 18 (05) :512-524
[3]  
BERNARD V, 1992, J NEUROSCI, V12, P3591
[4]   Potential role of muscarinic receptors in schizophrenia [J].
Bymaster, FP ;
Shannon, HE ;
Rasmussen, K ;
DeLapp, NW ;
Ward, JS ;
Calligaro, DO ;
Mitch, CH ;
Whitesitt, C ;
Ludvigsen, TS ;
Sheardown, M ;
Swedberg, M ;
Rasmussen, T ;
Olesen, PH ;
Jeppesen, L ;
Sauerberg, P ;
Fink-Jensen, A .
LIFE SCIENCES, 1999, 64 (6-7) :527-534
[5]  
BYMASTER FP, 2002, UNPUB EUR J NEUROSCI
[6]   MUSCARINIC RECEPTORS - CHARACTERIZATION, COUPLING AND FUNCTION [J].
CAULFIELD, MP .
PHARMACOLOGY & THERAPEUTICS, 1993, 58 (03) :319-379
[7]  
Caulfield MP, 1998, PHARMACOL REV, V50, P279
[8]   MUSCARINIC M(1)-RECEPTOR AGONISTS - POTENTIAL IN THE TREATMENT OF ALZHEIMERS-DISEASE [J].
CUTLER, NR ;
SRAMEK, JJ .
CNS DRUGS, 1995, 3 (06) :467-481
[9]   DOPAMINERGIC REGULATION OF STRIATAL CHOLINERGIC INTERNEURONS - AN INVIVO MICRODIALYSIS STUDY [J].
DAMSMA, G ;
DEBOER, P ;
WESTERINK, BHC ;
FIBIGER, HC .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1990, 342 (05) :523-527
[10]  
DUTTAROY A, 2000, SOC NEUR ABSTR, V26, P1644